The results of the study, led by Clínic-IDIBAPS researchers, could contribute to improving diagnosis of the disease.
Interview with Dr. Mª Josep Martí, neurologist and head of the IDIBAPS Parkinson’s Disease and other Neurodegenerative Movement Disorders research gr1
Treatment with gene therapy, however, reverses the damage caused by deposits of α-synuclein in the neuron circuits and alleviates neuropsychiatric sy1
Researchers at Hospital Clínic-IDIBAPS have observed changes in the phosphorylation pattern of certain proteins associated with a mutation in the gen1
This methodology makes it possible to determine the risk of developing these diseases before symptoms appear in people with REM sleep behavior disord1
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group of1
